Alnylam Shows Efficacy, Safety With Lumasiran In Vulnerable Pediatric Patients

ILLUMINATE-B Is The Second Successful Phase III Study In Primary Hyperoxaluria 1

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.